Collegium Pharmaceutical (COLL) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Collegium Pharmaceutical (COLL) over the last 9 years, with Q4 2024 value amounting to $13.5 million.
- Collegium Pharmaceutical's Accumulated Depreciation & Amortization rose 3984.29% to $13.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $13.5 million, marking a year-over-year increase of 3984.29%. This contributed to the annual value of $13.5 million for FY2024, which is 3984.29% up from last year.
- According to the latest figures from Q4 2024, Collegium Pharmaceutical's Accumulated Depreciation & Amortization is $13.5 million, which was up 3984.29% from $9.7 million recorded in Q4 2023.
- In the past 5 years, Collegium Pharmaceutical's Accumulated Depreciation & Amortization ranged from a high of $13.5 million in Q4 2024 and a low of $3.1 million during Q4 2020
- Its 5-year average for Accumulated Depreciation & Amortization is $7.5 million, with a median of $6.3 million in 2022.
- As far as peak fluctuations go, Collegium Pharmaceutical's Accumulated Depreciation & Amortization skyrocketed by 3356.64% in 2020, and later skyrocketed by 5366.49% in 2021.
- Over the past 5 years, Collegium Pharmaceutical's Accumulated Depreciation & Amortization (Quarter) stood at $3.1 million in 2020, then skyrocketed by 53.66% to $4.7 million in 2021, then skyrocketed by 34.65% to $6.3 million in 2022, then surged by 53.06% to $9.7 million in 2023, then surged by 39.84% to $13.5 million in 2024.
- Its last three reported values are $13.5 million in Q4 2024, $9.7 million for Q4 2023, and $6.3 million during Q4 2022.